SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BSD Medical (Long Term Investment Oriented)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: pleonastic1/14/2013 11:12:16 AM
   of 178
 
More MTX-180 sales -- to Turkey -- multiple units but number not stated:

<BSD Medical Corporation ( BSDM) (Company or BSD) ( www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the Company has sold multiple MicroThermX® Microwave Ablation (MicroThermX®) systems and antennas to ADA Medikal (ADA), pursuant to their exclusive distribution agreement signed in October 2012 for the MicroThermX® in Turkey. ADA is a leading, medical, specialty distributor in Turkey with offices in the major metropolitan areas. ADA represents a number of major medical device companies and sells strategically adjacent products to the same clinicians targeted for the MicroThermX®.

Turkey is an important international market with a population of more than 73 million and the world's 15th largest economy. ADA projects that they will need to order a significant number of systems to address the market for the MicroThermX® in Turkey. Turkey's location at the crossroads of Europe and Asia and its growing economy have led to its recognition as a regional power in the Middle East.>

A usage level of only two disposable applicators ("antennas"; $2000/ea) per week would mean 50*$4000=$200,000 per year. Up to 3 antennas can be used per treatment, for a single tumor -- and patients can have several tumors. As usage grows, more than one treatment per day is easily expectable, or over 250*$4000=$1 million per year per machine for the disposables. There are, I believe, more than ten MTX's in operation now; and there are many hundreds of hospitals in the U.S. alone that could profit handsomely from this equipment. You do the rest of the rough math.
:-)

Remember:

1) The MTX is the way-out best microwave ablation machine.

2) Microwave ablation (MWA) is fundamentally far better than the present Interventional Oncology leader (radio-frequency ablation, RFA).

3) IO is a quite sizable, rapidly growing medical practice (something like $5 to $10 billion per year and growing at about 14%/yr)

There -- easy as 1,2,3. :-)

Oh! Then there are the BIG machines -- the *benign*, highly-effective BSD-2000 series; which could supplement or largely replace radiotherapy machines and chemotherapy drugs (both of which involve serious, inherent side effects).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext